Aiolos Bio

Windward Bio

The company develops long-acting monoclonal antibodies for patients with serious respiratory and dermatological diseases, including severe asthma, chronic obstructive pulmonary disease and atopic dermatitis.

Upstream Bio

The company develops monoclonal antibody therapies for patients with chronic inflammatory and respiratory diseases, including asthma and chronic rhinosinusitis.

Kinaset Therapeutics

This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.

Apogee Therapeutics

This biotechnology company develops monoclonal antibody therapies for patients with inflammatory and immunological diseases, including atopic dermatitis, asthma and chronic obstructive pulmonary disease.

Areteia Therapeutics

The company develops an oral medication for patients with eosinophilic asthma to reduce inflammation and manage their condition.

Connect Biopharma

This clinical-stage biopharmaceutical company develops immune-modulating therapies for patients suffering from asthma and chronic obstructive pulmonary disease.

Belenos Biosciences

This clinical-stage biotechnology company develops long-acting bispecific antibody therapeutics for patients with chronic inflammatory diseases such as asthma and atopic dermatitis.

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.